At the BR1DGE symposium at ISPAD 2024, leading experts shared their insights on the importance of screening for islet autoantibodies (IAb) to identify early-stage (Stage 1 and 2) autoimmune type 1 diabetes (T1D). Early identification, followed by monitoring and education, is crucial to help prepare people for a life with T1D.
This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.